U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
78.27
+0.95 (1.23%)
Aug 26, 2026, 4:00 PM EDT - Market closed

U.S. Physical Therapy Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, U.S. Physical Therapy stock has a consensus rating of "Buy" and an average price target of $95. The average 1-year stock price forecast is 21.37% higher than the current stock price, while the lowest is $88 (+12.43%) and the highest is $100 (+27.76%).

Price Target: $95 (+21.37%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$88$95$97$100
Change+12.43%+21.37%+23.93%+27.76%

Analyst Ratings

The average analyst rating for U.S. Physical Therapy stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy222222
Buy444444
Hold111111
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 14, 2026
Barrington
Barrington
Buy
Maintains
$90$98
BuyMaintains$90$98+25.21%Aug 10, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$88
BuyReiterates$88+12.43%Aug 6, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$100$90
BuyMaintains$100$90+14.99%May 19, 2026
Citizens JMP
Citizens JMP
Buy
Maintains
$113$98
BuyMaintains$113$98+25.21%May 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
846.20M
from 773.34M
Increased by 9.42%
Revenue Next Year
908.46M
from 846.20M
Increased by 7.36%
EPS This Year
2.89
from 2.63
Increased by 10.02%
EPS Next Year
3.38
from 2.89
Increased by 16.90%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
489.72M547.60M598.63M664.43M773.34M846.20M
Revenue Growth
17.06%11.82%9.32%10.99%16.39%9.42%
Gross Profit
117.18M126.04M136.64M146.13M171.02M167.55M
Gross Margin
23.93%23.02%22.83%21.99%22.11%19.80%
Operating Income
70.65M65.99M69.73M69.99M80.70M86.61M
Net Income
40.83M32.16M28.24M31.42M39.58M54.95M
EPS
----2.632.89
EPS Growth
----7.35%10.02%
Forward PE
30.0229.1534.0232.9327.6727.05
Dividend / Share
1.461.641.721.761.801.84
Dividend Growth
356.25%12.33%4.88%2.33%2.27%2.22%
Free Cash Flow
48.15M33.22M66.08M46.10M73.92M68.16M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High851.0M
Avg846.2M
Low838.3M

Revenue Growth

Revenue Growth202620272028
High
10.0%
Avg
9.4%
Low
8.4%

EPS Forecast

EPS202620272028
High3.14
Avg2.89
Low2.70

EPS Growth

EPS Growth202620272028
High
19.4%
Avg
10.0%
Low
2.7%